A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2(+) Solid Cancer
Article Details
-
Date Published
January 3, 2023
Hombach AA, Ambrose C, Lobb R, Rennert P, Abken H. A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2(+) Solid Cancer. Cells. 2023 Jan 7. 12doi:10.3390/cells12020248. PMID: 36672182